Want to join the conversation?
Biopharmaceutical company $CELG and the Lymphoma Study Association (LYSA) said the Lymphoma Academic Research Organisation (LYSARC) has reported initial data from a Phase III randomized double-blind study, REMARC. Study achieved primary endpoint of a significant improvement in progression-free survival for patients receiving REVLIMID.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.